EX-10.26-K·CIK 1981662·0001213900-26-122681

Form of Limited Waiver and Repurchase Agreement

View original filing on SEC EDGAR → ·  seen Nov 20, 2026, 16:01 EST

Exhibit 10.2

LIMITED WAIVER AND REPURCHASE AGREEMENT

** **

This Limited Waiver and Repurchase Agreement (the “Agreement”), dated as of November 19, 2026, is by and between NewGenIvf Group Limited, a business company incorporated under the laws of the British Virgin Islands (the “Company”), and the holder identified on the signature page attached hereto (the “Holder”).

R E C I T A L S

A.Reference is hereby made to (i) that certain Securities Purchase Agreement, dated as of August 7, 2024 (as amended, modified or waived from time to time, the “2024 Securities Purchase Agreement”), by and among the Company and the investors signatory thereto, pursuant to which, among other things, the Company issued to the Holder a senior convertible note (the “2024 Note”) and certain warrants (the “Existing Warrants”); (ii) that certain Securities Purchase Agreement, dated as of April 1, 2025 (as amended, modified or waived from time to time, the “2025 Securities Purchase Agreement”, and together with the 2024 Securities Purchase Agreement, the “Existing Securities Purchase Agreements”), by and among the Company and the investors signatory thereto, pursuant to which, among other things, the Company issued to the Holder a senior convertible note, dated as of June 3, 2025 (the “2025 Note” and, together with the 2024 Note and the Existing Warrants, the “Existing Securities”); (iii) that certain Repurchase and Forbearance Agreement, dated as of June 15, 2026, by and between the Company and the Holder (the “Forbearance Agreement”), pursuant to which, among other things, the Company agreed to repurchase the Existing Securities; and (iv) that certain Amendment and Exchange Agreement, dated as of August 11, 2026, by and between the Company and the Holder (the “Exchange Agreement”), pursuant to which, among other things, the Company issued to the Holder, in exchange for the Existing Securities and in reliance on Section 3(a)(9) of the Securities Act of 1933, as amended, a new senior convertible note (the “Exchange Note”). Capitalized terms used but not defined herein shall have the meanings set forth in the Exchange Agreement.

B.The Company desires to enter into a securities purchase agreement (the “Subsequent Placement Agreement”) with one or more investors (the “New Investors”), in one or more offerings, pursuant to which, among other things, the Company would issue and sell to the New Investors 1,150,570 of the Company’s Class A Ordinary Shares, no par value per share (“Ordinary Shares”) and 70,278,000 pre-funded warrants, which are exercisable into Ordinary Shares of the Company (the “Proposed Offering”).

C.The Company desires that the Holder waive, in part, the definition of “Alternate Conversion Price” in Section 32(g) of the Exchange Note, such that during the period commencing on the 10th Trading Day (as defined in the Exchange Note) after the public announcement of the Proposed Offering through and including the 70th Trading Day after the public announcement of the Proposed Offering (the “Waiver Period”) clause (y) of Section 32(g) shall be deemed to be equal to “76% of the lowest daily VWAP during the seven (7) consecutive Trading Day period ending on and including the Trading Day immediately preceding the delivery or deemed delivery of the applicable Conversion Notice” (the “Limited Waiver”).

NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants hereinafter contained, the Company and the Holder agree as follows:

A G R E E M E N T

1.  Limited Waiver. Effective as of the Effective Date (as defined below), the Holder hereby grants the Limited Waiver.

2.  Limitation of Waiver. The Limited Waiver set forth herein constitutes a one-time waiver and is limited to the matters expressly waived herein and should not be construed as an indication that the Holder would be willing to agree to any future modifications to, consent to, or waiver of any of the terms of any other agreement, instrument or security or any modifications to, consents to, or waiver of any default that may exist or occur thereunder.

3.  Amendments; Ratifications.

3.1  On and after the Effective Date (as defined below), each of the defined terms Transaction Documents (as defined in the Existing Securities Purchase Agreements) and Exchange Documents (as defined in the Exchange Agreement) are hereby amended to include this Agreement.

3.2  Except as otherwise expressly provided herein, each of the Transaction Documents (as defined in the Existing Securities Purchase Agreements) and the Exchange Documents is, and shall continue to be, in full force and effect and is hereby ratified and confirmed in all respects.

4.  Fees and Expenses. The Company shall reimburse Kelley Drye & Warren LLP (counsel to the Holder) in an aggregate non-accountable amount of $15,000 for costs and expenses incurred by it in connection with the drafting and negotiation of this Agreement (the “Legal Fee Amount”). Each party to this Agreement shall bear its own expenses in connection with the structuring, documentation, negotiation and closing of the transactions contemplated hereby, except as provided in the previous sentence and except that the Company shall be responsible for the payment of any placement agent’s fees, financial advisory fees, transfer agent fees and Depository Trust Company fees relating to or arising out of the transactions contemplated hereby.

5.  Effective Date. This Agreement shall be deemed effective as of the date hereof upon the later of (x) the date on which this Agreement has been executed and delivered by each of the Company and the Holder and (y) the date on which the Company has paid the Legal Fee Amount in full (the “Effective Date”).

6.  Mandatory Repurchase. Simultaneously with the initial closing of the Proposed Offering, the Holder shall sell, and the Company shall repurchase, $584,112 of the outstanding principal of the Exchange Note (the “Repurchased Note”, and such repurchase, the “Repurchase”) for a repurchase price of $625,000 the “Repurchase Price”). In lieu of the Company paying the Repurchase Price directly to the Holder, the Company hereby directs the Holder to net fund the purchase price of securities to be acquired by the Holder at the initial closing of the Proposed Offering by a cash amount equal to the Repurchase Price. Immediately following the consummation of the Repurchase, the Repurchased Note shall automatically be cancelled and shall no further force or effect. For the avoidance of doubt, (i) the outstanding principal balance of the Exchange Note immediately prior to the Proposed Offering is $5,769,469 and (ii) after giving effect to the Repurchase, the outstanding principal balance of the Exchange Note shall be $5,185,357.

7.  Disclosure. The Company shall, on or before 8:00 a.m., New York City Time, on or prior to the first (1st) Business Day after the date of this Agreement, and in any event prior to the public announcement of the Proposed Offering, make public disclosure describing the terms of the transactions contemplated hereby (the “Public Disclosure”). From and after the date of the Public Disclosure, the Company shall have disclosed all material, non-public information (if any) provided up to such time to the Holder by the Company or any of its Subsidiaries or any of their respective officers, directors, employees or agents. In addition, effective upon the making of the Public Disclosure, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement with respect to the transactions contemplated by this Agreement or as otherwise disclosed in the Public Disclosure, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, affiliates, employees or agents, on the one hand, and the Holder or any of its affiliates, on the other hand, shall terminate. Neither the Company, its Subsidiaries nor the Holder shall issue any press releases or any other public statements with respect to this Agreement; provided, that the Company shall be entitled, without the prior approval of the Holder, to make a press release or other public disclosure with respect to this Agreement (i) in substantial conformity with the Public Disclosure and contemporaneously therewith or (ii) as is required by applicable law and regulations (provided that in the case of clause (i) the Holder shall be consulted by the Company in connection with any such press release or other public disclosure prior to its release to the extent the Holder is named in such press release or disclosure). Without the prior written consent of the Holder (which may be granted or withheld in the Holder’s sole discretion), except as required by applicable law, the Company shall not (and shall cause each of its Subsidiaries and affiliates to not) disclose the name of the Holder in any filing, announcement, release or otherwise.

8.  Miscellaneous Provisions. Sections 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 25, 26, and 27 of the Exchange Agreement are hereby incorporated by reference herein, mutatis mutandis.

[The remainder of the page is intentionally left blank.]

2

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.

COMPANY:
NEWGENIVF GROUP LIMITED
By:
Name:
Title:
3

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.

HOLDER:
**[●]**By:
Name:
Title:

4

Back to all agreements